Blue chip stocks provide stability, dividends, and less volatility than tech stocks. If undervalued, they're great investments. So, here are 9 most undervalued blue chip stocks.
STOCK PRICE : $43.94P/E RATIO : 9.36
Pfizer
01.
NYSE : PFE
The stock is underpriced even after the success of its Covid-19 vaccine.
STOCK PRICE : $38.92P/E RATIO : 21.64
Conagra Brands
02.
NYSE : CAG
The stock is around 30% down due to fall in sales and earnings.
STOCK PRICE : $181.12P/E RATIO : 10.13
Chevron Corporation
03.
NYSE : CVX
Low PE Ratio makes the stock attractive.
STOCK PRICE : $95.77P/E RATIO : 8.63
Novartis AG
04.
NYSE : NVS
Trading at around 12 times earnings, Novartis stock appears to be a bargain compared to other Big Pharma Companies.
STOCK PRICE : $158.79P/E RATIO : 22.76
Target
05.
NYSE : TGT
Attractive due to its low P/E ratio and strong dividend.
STOCK PRICE : $132.77P/E RATIO : 10.68
3M
06.
NYSE : MMM
The stock fell 23% due to ongoing lawsuits and litigations. But, the company is still strong financially.
STOCK PRICE : $153.54P/E RATIO : 9.16
JP MOrgan
07.
NYSE : JPM
Shares are 16% down despite rising interest rates.
STOCK PRICE : $37.41P/E RATIO : 7.53
Verizon
08.
NYSE : VZ
The company stock has not recovered even after resolving lead shielding issue.
STOCK PRICE : $122.31P/E RATIO : 1111.91
AMD
09.
NASDAQ : AMD
The semiconductor company's share price has halved.